FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294719076> ?p ?o ?g. }

• W4294719076 abstract "Objective: To compare the effectiveness of second line injectables containing shorter (duration 9-12 months) and longer treatment regimens (LTR, duration ≥ 20 months) among multidrug-resistant tuberculosis (MDR-TB) patients with no documented resistance and history of treatment with any second-line anti-TB drug (SLD) for ≥ 1 month. Methods: This was an observational cohort study of MDR-TB patients treated at eight PMDT units in Pakistan. Patients' data from baseline until treatment outcomes were collected from Electronic Nominal Recording and Reporting System. The treatment outcomes of cured and treatment completed were grouped together as successful, whereas death, treatment failure, and lost to follow-up were collectively grouped as unsuccessful outcomes. Time to sputum culture conversion (SCC) was analyzed using the Kaplan-Meier method and the differences between groups were compared through the log-rank test. Multivariate Cox proportional hazards and binary logistic regression analyses were used to find predictors of time to SCC and unsuccessful treatment outcomes. A p-value < 0.05 was considered statistically significant. Results: A total 701 eligible MDR-TB patients [313 treated with shorter treatment regimen (STR) and 388 treated with LTR at eight centres in Pakistan were evaluated]. Time to achieve SCC was significantly shorter in STR group [mean: 2.03 months, 95% confidence interval (CI):1.79-2.26] than in LTR group (mean: 2.69 months, 95% CI: 2.35-3.03) (p-value<0.001, Log-rank test). Treatment success was higher in STR (83.7%) than in LTR (73.2%) group (p-value <0.001) due to high cure (79.9% vs. 70.9%, p-value = 0.006) and low death (9.9% vs. 18.3%, p-value = 0.002) rates with STR. Treatment with STR emerged the only predictor of early SCC [adjusted Hazards ratio (aHR) = 0.815, p-value = 0.014], whereas, patient's age of 41-60 (OR = 2.62, p-value<0.001) and >60 years (OR = 5.84, p-value<0.001), baseline body weight of 31-60 (OR = 0.36, p-value = 0.001) and >60 kg (OR = 0.23, p-value <0.001), and treatment with LTR (OR = 1.88, p-value = 0.001) had statistically significant association with unsuccessful treatment outcomes. Conclusion: STR exhibited superior anti-microbial activity against MDR-TB. When compared LTR, treatment with STR resulted in significantly early SCC, high cure, and lower death rates among MDR-TB patients who had no documented resistance and history of treatment with any SLD ≥ 1 month." @default.
• W4294719076 created "2022-09-06" @default.
• W4294719076 creator A5006089929 @default.
• W4294719076 creator A5022425908 @default.
• W4294719076 creator A5025581939 @default.
• W4294719076 creator A5034666104 @default.
• W4294719076 creator A5050455291 @default.
• W4294719076 creator A5060557076 @default.
• W4294719076 creator A5071121555 @default.
• W4294719076 creator A5076422600 @default.
• W4294719076 creator A5083347826 @default.
• W4294719076 date "2022-09-06" @default.
• W4294719076 modified "2023-09-27" @default.
• W4294719076 title "Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country" @default.
• W4294719076 cites W2000759284 @default.
• W4294719076 cites W2007102363 @default.
• W4294719076 cites W2042369892 @default.
• W4294719076 cites W2052166920 @default.
• W4294719076 cites W2083509737 @default.
• W4294719076 cites W2125024131 @default.
• W4294719076 cites W2129831514 @default.
• W4294719076 cites W2167629505 @default.
• W4294719076 cites W2168509294 @default.
• W4294719076 cites W2292308473 @default.
• W4294719076 cites W2326504873 @default.
• W4294719076 cites W2335742497 @default.
• W4294719076 cites W2417325503 @default.
• W4294719076 cites W2532278194 @default.
• W4294719076 cites W2561712576 @default.
• W4294719076 cites W2561953156 @default.
• W4294719076 cites W2586316020 @default.
• W4294719076 cites W2586778197 @default.
• W4294719076 cites W2617726015 @default.
• W4294719076 cites W2740681594 @default.
• W4294719076 cites W2749992547 @default.
• W4294719076 cites W2770976846 @default.
• W4294719076 cites W2791308452 @default.
• W4294719076 cites W2795574439 @default.
• W4294719076 cites W2891690058 @default.
• W4294719076 cites W2911325500 @default.
• W4294719076 cites W2921026546 @default.
• W4294719076 cites W2942730003 @default.
• W4294719076 cites W2942940267 @default.
• W4294719076 cites W2976053014 @default.
• W4294719076 cites W2995747718 @default.
• W4294719076 cites W3007016101 @default.
• W4294719076 cites W3010945518 @default.
• W4294719076 cites W3036242113 @default.
• W4294719076 cites W3137439919 @default.
• W4294719076 cites W3203767774 @default.
• W4294719076 cites W4200150915 @default.
• W4294719076 cites W4210313021 @default.
• W4294719076 cites W4214935432 @default.
• W4294719076 cites W4280503073 @default.
• W4294719076 doi "https://doi.org/10.3389/fphar.2022.973713" @default.
• W4294719076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36160454" @default.
• W4294719076 hasPublicationYear "2022" @default.
• W4294719076 type Work @default.
• W4294719076 citedByCount "0" @default.
• W4294719076 crossrefType "journal-article" @default.
• W4294719076 hasAuthorship W4294719076A5006089929 @default.
• W4294719076 hasAuthorship W4294719076A5022425908 @default.
• W4294719076 hasAuthorship W4294719076A5025581939 @default.
• W4294719076 hasAuthorship W4294719076A5034666104 @default.
• W4294719076 hasAuthorship W4294719076A5050455291 @default.
• W4294719076 hasAuthorship W4294719076A5060557076 @default.
• W4294719076 hasAuthorship W4294719076A5071121555 @default.
• W4294719076 hasAuthorship W4294719076A5076422600 @default.
• W4294719076 hasAuthorship W4294719076A5083347826 @default.
• W4294719076 hasBestOaLocation W42947190761 @default.
• W4294719076 hasConcept C126322002 @default.
• W4294719076 hasConcept C142724271 @default.
• W4294719076 hasConcept C151956035 @default.
• W4294719076 hasConcept C2776301714 @default.
• W4294719076 hasConcept C2777025531 @default.
• W4294719076 hasConcept C2777768864 @default.
• W4294719076 hasConcept C2777975735 @default.
• W4294719076 hasConcept C2779912665 @default.
• W4294719076 hasConcept C2781069245 @default.
• W4294719076 hasConcept C2781413609 @default.
• W4294719076 hasConcept C44249647 @default.
• W4294719076 hasConcept C50382708 @default.
• W4294719076 hasConcept C66339696 @default.
• W4294719076 hasConcept C71924100 @default.
• W4294719076 hasConcept C72563966 @default.
• W4294719076 hasConceptScore W4294719076C126322002 @default.
• W4294719076 hasConceptScore W4294719076C142724271 @default.
• W4294719076 hasConceptScore W4294719076C151956035 @default.
• W4294719076 hasConceptScore W4294719076C2776301714 @default.
• W4294719076 hasConceptScore W4294719076C2777025531 @default.
• W4294719076 hasConceptScore W4294719076C2777768864 @default.
• W4294719076 hasConceptScore W4294719076C2777975735 @default.
• W4294719076 hasConceptScore W4294719076C2779912665 @default.
• W4294719076 hasConceptScore W4294719076C2781069245 @default.
• W4294719076 hasConceptScore W4294719076C2781413609 @default.
• W4294719076 hasConceptScore W4294719076C44249647 @default.
• W4294719076 hasConceptScore W4294719076C50382708 @default.
• W4294719076 hasConceptScore W4294719076C66339696 @default.
• W4294719076 hasConceptScore W4294719076C71924100 @default.
• W4294719076 hasConceptScore W4294719076C72563966 @default.

• next